1Department of Biological Sciences, University of Calgary, Alberta, Canada.
Researchers engineered monomeric streptavidin with reversible biotin binding. This modified protein, designed to prevent aggregation, shows promise for various biotechnological applications requiring controlled biotin interaction.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: